About this Journal Submit a Manuscript Table of Contents
Biochemistry Research International
Volume 2012 (2012), Article ID 716056, 6 pages
http://dx.doi.org/10.1155/2012/716056
Research Article

Reduced TCA Flux in Diabetic Myotubes: Determined by Single Defects?

1Laboratory of Molecular Physiology, Department of Pathology, Odense University Hospital, 5000 Odense, Denmark
2Department of Endocrinology, Odense University Hospital, 5000 Odense, Denmark

Received 9 November 2011; Revised 3 January 2012; Accepted 12 January 2012

Academic Editor: Paul R. Gooley

Copyright © 2012 Michael Gaster. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Gaster, I. Petersen, K. Hojlund, P. Poulsen, and H. Beck-Nielsen, “The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity,” Diabetes, vol. 51, no. 4, pp. 921–927, 2002. View at Scopus
  2. M. Gaster, A. C. Rustan, V. Aas, and H. Beck-Nielsen, “Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes,” Diabetes, vol. 53, no. 3, pp. 542–548, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Gaster, A. C. Rustan, and H. Beck-Nielsen, “Differential utilization of saturated palmitate and unsaturated oleate: evidence from cultured myotubes,” Diabetes, vol. 54, no. 3, pp. 648–656, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Gaster, “Reduced lipid oxidation in myotubes established from obese and type 2 diabetic subjects,” Biochemical and Biophysical Research Communications, vol. 382, no. 4, pp. 766–770, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. A. J. Wensaas, A. C. Rustan, M. Just, R. K. Berge, C. A. Drevon, and M. Gaster, “Fatty acid incubation of myotubes from humans with type 2 diabetes leads to enhanced release of beta-oxidation products because of impaired fatty acid oxidation: effects of tetradecylthioacetic acid and eicosapentaenoic acid,” Diabetes, vol. 58, no. 3, pp. 527–535, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Gaster, “Insulin resistance and the mitochondrial link. Lessons from cultured human myotubes,” Biochimica et Biophysica Acta, vol. 1772, no. 7, pp. 755–765, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Gaster, “Reduced TCA flux in diabetic myotubes: a governing influence on the diabetic phenotype?” Biochemical and Biophysical Research Communications, vol. 387, no. 4, pp. 651–655, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. A. J. Janssen, F. J. Trijbels, R. C. Sengers et al., “Measurement of the energy-generating capacity of human muscle mitochondria: diagnostic procedure and application to human pathology,” Clinical Chemistry, vol. 52, no. 5, pp. 860–871, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. D. E. Befroy, K. F. Petersen, S. Dufour et al., “Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients,” Diabetes, vol. 56, no. 5, pp. 1376–1381, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Schrauwen and M. K. Hesselink, “Reduced tricarboxylic acid cycle flux in type 2 diabetes mellitus?” Diabetologia, vol. 51, no. 9, pp. 1694–1697, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Gaster and H. Beck-Nielsen, “Triacylglycerol accumulation is not primarily affected in myotubes established from type 2 diabetic subjects,” Biochimica et Biophysica Acta, vol. 1761, no. 1, pp. 100–110, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Ortenblad, M. Mogensen, I. Petersen et al., “Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect,” Biochimica et Biophysica Acta, vol. 1741, no. 1-2, pp. 206–214, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. A. D. Minet and M. Gaster, “ATP synthesis is impaired in isolated mitochondria from myotubes established from type 2 diabetic subjects,” Biochemical and Biophysical Research Communications, vol. 402, no. 1, pp. 70–74, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. A. D. Minet and M. Gaster, “The dynamic equilibrium between ATP synthesis and ATP consumption is lower in isolated mitochondria from myotubes established from type 2 diabetic subjects compared to lean control,” Biochemical and Biophysical Research Communications, vol. 409, pp. 591–595, 2011.
  15. T. E. Thingholm, S. Bak, H. Beck-Nielsen, O. N. Jensen, and M. Gaster, “Characterization of human myotubes from type 2 diabetic and non-diabetic subjects using complementary quantitative mass spectrometric methods,” Molecular & Cellular Proteomics, vol. 10, Article ID M110, 2011.
  16. A. D. Minet and M. Gaster, “Hydrogen peroxide production is not primarily increased in human myotubes established from type 2 diabetic subjects,” Journal of Clinical Endocrinology & Metabolism, vol. 96, pp. E1486–E1490, 2011.
  17. M. Gaster and H. Beck-Nielsen, “The reduced insulin-mediated glucose oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin—evidence from cultured myotubes,” Biochimica et Biophysica Acta, vol. 1690, no. 1, pp. 85–91, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Gaster, S. R. Kristensen, H. Beck-Nielsen, and H. D. Schroder, “A cellular model system of differentiated human myotubes,” Acta Pathologica, Microbiologica et Immunologica Scandinavica, vol. 109, no. 11, pp. 735–744, 2001. View at Scopus
  19. M. Gaster, H. D. Schroder, A. Handberg, and H. Beck-Nielsen, “The basal kinetic parameters of glycogen synthase in human myotube cultures are not affected by chronic high insulin exposure,” Biochimica et Biophysica Acta, vol. 1537, no. 3, pp. 211–221, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Gaster, H. Beck-Nielsen, and H. D. Schroder, “Proliferation conditions for human satellite cells. The fractional content of satellite cells,” Acta Pathologica, Microbiologica et Immunologica Scandinavica, vol. 109, no. 11, pp. 726–734, 2001. View at Scopus
  21. M. Gaster, “Insulin resistance and the mitochondrial link. Lessons from cultured human myotubes,” Biochimica et Biophysica Acta, vol. 1772, no. 7, pp. 755–765, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. C. M. Frederiksen, K. Hojlund, L. Hansen et al., “Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes,” Diabetologia, vol. 51, no. 11, pp. 2068–2077, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. M. E. Patti, A. J. Butte, S. Crunkhorn et al., “Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8466–8471, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. V. K. Mootha, C. M. Lindgren, K. F. Eriksson et al., “PGC-1 alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes,” Nature Genetics, vol. 34, no. 3, pp. 267–273, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Lin, R. W. Brownsey, and K. M. MacLeod, “Regulation of mitochondrial aconitase by phosphorylation in diabetic rat heart,” Cellular and Molecular Life Sciences, vol. 66, no. 5, pp. 919–932, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Gaster, “Mitochondrial mass is inversely correlated to complete lipid oxidation in human myotubes,” Biochemical and Biophysical Research Communications, vol. 404, pp. 1023–1028, 2011.
  27. M. A. Abdul-Ghani, R. Jani, A. Chavez, M. Molina-Carrion, D. Tripathy, and R. A. De Fronzo, “Mitochondrial reactive oxygen species generation in obese non-diabetic and type 2 diabetic participants,” Diabetologia, vol. 52, no. 4, pp. 574–582, 2009. View at Publisher · View at Google Scholar · View at Scopus